MEDRAD, INC. Announces European Approval And Launch Of The Cotavance(TM) Drug Eluting Balloon With Paccocath(R) Technology
WARRENDALE, Pennsylvania, May 17, 2011 /PRNewswire/ -- MEDRAD, INC., a business of Bayer HealthCare, today announced it has received CE Mark for its Cotavance(TM) Paclitaxel Coated Balloon…